| [1] |
ZHAO H, ZHUO T, HAO X, et al. Effect of diabetes on the prognosis, serum inflammatory factors, and quality of life of patients with lower extremity arteriosclerosis obliterans after vascular intervention: A retrospective comparative cohort study[J]. Ann Palliat Med, 2022, 11(8): 2720-2729. doi: 10.21037/apm-22-827 .
doi: 10.21037/apm-22-827
|
| [2] |
LI Y P, SU T, XUE X L, et al. Application of buried auricular point combined with Wenjing Sanhan prescription in arteriosclerosis obliterans patients with resting pain[J]. World J Clin Cases, 2024, 12(24): 5558-5567. doi: 10.12998/wjcc.v12.i24.5558 .
doi: 10.12998/wjcc.v12.i24.5558
|
| [3] |
SU Z, LI Y, WANG C, et al. Directional atherectomy combined with drug-coated balloon angioplasty for superficial femoral arteriosclerosis obliterans[J]. Annals, 2023, 105(7): 627-631. doi: 10.1308/rcsann.2022.0164 .
doi: 10.1308/rcsann.2022.0164
|
| [4] |
ZHANG C, CHEN S. Percutaneous transluminal angioplasty with stenting for the treatment of lower limb arteriosclerosis obliterans[J]. Wideochir Inne Tech Maloinwazyjne, 2024, 19(4): 465-469. doi: 10.20452/wiitm.2024.17915 .
doi: 10.20452/wiitm.2024.17915
|
| [5] |
DEL MAR VILA M, IGUAL L, REMESEIRO B, et al. Polyvascular subclinical atherosclerosis: Correlation between ankle brachial index and carotid atherosclerosis in a population-based sample[J]. Angiology, 2023, 74(5): 443-451. doi: 10.1177/00033197221110720 .
doi: 10.1177/00033197221110720
|
| [6] |
YAN F, DING H, SUN Z, et al. Glycoside combinations of Buyang Huanwu decoction ameliorate atherosclerosis via STAT3, HIF-1, and VEGF[J]. Naunyn Schmiedeberg′s Arch Pharmacol, 2023, 396(6): 1187-1203. doi: 10.1007/s00210-023-02389-6 .
doi: 10.1007/s00210-023-02389-6
|
| [7] |
TIAN S Y. Systemic immune-inflammation index predicts restenosis after interventions for lower extremity arteriosclerosis obliterans[J]. Heart Surg Forum, 2023, 26(3): E225-E233. doi: 10.1532/hsf.5303 .
doi: 10.1532/hsf.5303
|
| [8] |
中华医学会外科学分会血管外科学组. 下肢动脉硬化闭塞症诊治指南[J]. 中华普通外科学文献(电子版), 2016, 10(1): 1-18. doi: 10.3877/cma.j.issn.1674-0793.2016.01.001 .
doi: 10.3877/cma.j.issn.1674-0793.2016.01.001
|
| [9] |
NORGREN L, HIATT W R, DORMANDY J A, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II)[J]. J Vasc Surg, 2007, 45(1): S5-S67. doi: 10.1016/j.jvs.2006.12.037 .
doi: 10.1016/j.jvs.2006.12.037
|
| [10] |
PARASKEVAS K I, POREDOS P, STANEK A, et al. Dyslipidemia and lower extremity arterial disease[J]. Int Angiol, 2024, 43(4): 450-457. doi: 10.23736/s0392-9590.24.05266-0 .
doi: 10.23736/s0392-9590.24.05266-0
|
| [11] |
TAKAHARA M, SOGA Y, IIDA O. Lower extremity arterial disease vs. coronary artery disease: Mortality differences after revascularization[J]. Eur Heart J, 2024, 45(18): 1634-1643. doi: 10.1093/eurheartj/ehae207 .
doi: 10.1093/eurheartj/ehae207
|
| [12] |
SECEMSKY E S, PARIKH S P, KOHI M, et al. Intravascular ultrasound guidance for lower extremity arterial and venous interventions[J]. EuroIntervention, 2022, 18(7): 598-608. doi: 10.4244/eij-d-21-00898 .
doi: 10.4244/eij-d-21-00898
|
| [13] |
CHEN J, TANG Y, SHEN Z, et al. Predicting and analyzing restenosis risk after endovascular treatment in lower extremity arterial disease: Development and assessment of a predictive nomogram[J]. J Endovasc Ther, 2024, 31(6): 1140-1149. doi: 10.1177/15266028231158294 .
doi: 10.1177/15266028231158294
|
| [14] |
LEE M, SMOLDEREN K G, IONESCU C, et al. Lower extremity symptoms and ankle-brachial index screening as predictors of cardiovascular outcomes in Black adults[J]. Vasc Med, 2023, 28(3): 197-204. doi: 10.1177/1358863X231151729 .
doi: 10.1177/1358863X231151729
|
| [15] |
张红松, 赵亚恒, 郑丽华, 等. 紫杉醇涂层球囊与普通球囊治疗腘动脉硬化闭塞症效果的倾向性评分匹配分析[J]. 中国普通外科杂志, 2022, 31(12): 1597-1604. doi: 10.7659/j.issn.1005-6947.2022.12.006 .
doi: 10.7659/j.issn.1005-6947.2022.12.006
|
| [16] |
何洋, 何欣燃, 黄超, 等. 置管溶栓结合多种腔内介入术在改善下肢动脉硬化闭塞症患者动脉硬化指标中的应用[J]. 实用医学杂志, 2025, 41(24): 3874-3882. doi: 10.3969/j.issn. 1006-5725.2025.24.011 .
doi: 10.3969/j.issn. 1006-5725.2025.24.011
|
| [17] |
LI X, ZHANG L, LI Q, et al. Construction of prediction models for novel subtypes in patients with arteriosclerosis obliterans undergoing endovascular therapy: An unsupervised machine learning study[J]. J Cardiothorac Surg, 2024, 19(1): 370. doi: 10.1186/s13019-024-02913-6 .
doi: 10.1186/s13019-024-02913-6
|
| [18] |
马松, 马海燕, 陈斌, 等. 踝肱指数联合Wagner分级预测糖尿病足预后应用价值的研究[J]. 中国糖尿病杂志, 2025, 33(8): 587-591. doi: 10.3969/j.issn.1006-6187.2025.08.006 .
doi: 10.3969/j.issn.1006-6187.2025.08.006
|
| [19] |
CHEN B, ZHANG Y, CHEN S, et al. The role of vascular endothelial growth factor in ischemic stroke[J]. Pharmazie, 2021, 76(4): 127. doi: 10.31083/ph.2021.1315 .
doi: 10.31083/ph.2021.1315
|
| [20] |
BALAKRISHNAN S, SENTHIL KUMAR B. Correlation of serum vascular endothelial growth factor and cardiovascular risk factors on collateral formation in patients with acute coronary artery syndrome[J]. Clin Anat, 2022, 35(5): 673-678. doi: 10.1002/ca.23890 .
doi: 10.1002/ca.23890
|
| [21] |
胡威龙, 王高尚, 张小兵, 等. 血清IL-8、VEGF水平与下肢动脉硬化闭塞症患者支架植入术后1年内支架内再狭窄的关系[J]. 中国普通外科杂志, 2024, 33(6): 943-951. doi: 10.7659/j.issn.1005-6947.2024.06.010 .
doi: 10.7659/j.issn.1005-6947.2024.06.010
|
| [22] |
LIU Y, CUI Y, ZHOU Z, et al. Relationship between angiotensin II, vascular endothelial growth factor, and arteriosclerosis obliterans[J]. Dis Markers, 2023, 2023(1): 1316821. doi: 10.1155/2023/1316821 .
doi: 10.1155/2023/1316821
|
| [23] |
ZHENG L, ZHAO B, ZHANG Z, et al. Berbamine promotes the repair of lower limb muscle damage in chronic limb-threatening ischemia by inhibiting local inflammation and NF-κB nuclear translocation[J]. Pharmaceuticals, 2024, 17(12): 1583. doi: 10.3390/ph17121583 .
doi: 10.3390/ph17121583
|
| [24] |
MARIACA K, SERÉS-NORIEGA T, VIÑALS C, et al. Neutrophil-to-lymphocyte ratio is independently associated with carotid atherosclerosis burden in individuals with type 1 diabetes[J]. Nutr Metab Cardiovasc Dis, 2024, 34(2): 395-403. doi: 10.1016/j.numecd.2023.09.017 .
doi: 10.1016/j.numecd.2023.09.017
|
| [25] |
王庆贺, 唐晨, 王宜梅, 等. 髂动脉钙化评分与下肢动脉硬化闭塞症患者药物涂层球囊联合支架植入术后下肢动脉再狭窄的相关性及其预测价值分析[J]. 中华医学杂志, 2024, 104(37): 3520-3527. doi: 10.3760/cma.j.cn112137-20240310-00539 .
doi: 10.3760/cma.j.cn112137-20240310-00539
|
| [26] |
丁洁, 李天润, 庄金满, 等. Rotarex机械血栓切除系统联合药物涂层球囊治疗股腘动脉支架内再狭窄[J]. 中国微创外科杂志, 2024, 24(3): 178-183. doi: 10.3969/j.issn.1009-6604.2024. 03.004 .
doi: 10.3969/j.issn.1009-6604.2024. 03.004
|
| [27] |
WANG X, WEN S, DU X, et al. SAA suppresses α-PD-1 induced anti-tumor immunity by driving TH2 polarization in lung adenocarcinoma[J]. Cell Death Dis, 2023, 14: 718. doi: 10.1038/s41419-023-06198-w .
doi: 10.1038/s41419-023-06198-w
|
| [28] |
XU Y, XU Y, LI Y, et al. Analysis of the Relationship Between the Changes of Serum SAA, LP-PLA2, sCD40L and Carotid Atherosclerosis Plaque in Patients with Acute Cerebral Infarction[J]. Altern Ther Health Med, 2024, 30(9): 47-53. PMID: .
pmid: 38330557
|
| [29] |
邓默, 贾米山, 田彦卿, 等. sTREM-1、PCT与MRP8/14对重症肺结核患者急性呼吸窘迫综合征的时序预测价值[J]. 实用医学杂志, 2025, 41(22): 3552-3557. doi: 10.3969/j.issn.1006-5725.2025.22.012 .
doi: 10.3969/j.issn.1006-5725.2025.22.012
|